Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The Worst thing about Brian's resignation

If it were done today, realistically no. If in three months, depending on what has transpired, possibly.

More to the point of my post though is that through a joining of two companies, the downside pressure of shorting that is often associated with an stand alone RS would be eliminated if done in a way that PTSC shares were converted to another company's certificates. Granted, the new company shares, or the other company's shares could be targeted as well, but it would be a bit less of a target that way than, for instance, PTSC to announced that on this date certain, provided shareholders approve, there will be a 1:10 stock split.

Share
New Message
Please login to post a reply